114 related articles for article (PubMed ID: 38788357)
1. Effectiveness and safety of computed tomography-guided high-dose-rate brachytherapy in treating recurrent hepatocellular carcinoma not amenable to repeated resection or radiofrequency ablation.
Auer TA; Anhamm M; Böning G; Fehrenbach U; Schöning W; Lurje G; Gebauer B; Collettini F
Eur J Surg Oncol; 2024 May; 50(7):108429. PubMed ID: 38788357
[TBL] [Abstract][Full Text] [Related]
2. Hepatocellular carcinoma: computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of large (5-7 cm) and very large (>7 cm) tumours.
Collettini F; Schnapauff D; Poellinger A; Denecke T; Schott E; Berg T; Wust P; Hamm B; Gebauer B
Eur Radiol; 2012 May; 22(5):1101-9. PubMed ID: 22173693
[TBL] [Abstract][Full Text] [Related]
3. CT-guided high-dose-rate brachytherapy of unresectable hepatocellular carcinoma.
Collettini F; Schreiber N; Schnapauff D; Denecke T; Wust P; Schott E; Hamm B; Gebauer B
Strahlenther Onkol; 2015 May; 191(5):405-12. PubMed ID: 25404063
[TBL] [Abstract][Full Text] [Related]
4. Unresectable colorectal liver metastases: percutaneous ablation using CT-guided high-dose-rate brachytherapy (CT-HDBRT).
Collettini F; Lutter A; Schnapauff D; Hildebrandt B; Puhl G; Denecke T; Wust P; Gebauer B
Rofo; 2014 Jun; 186(6):606-12. PubMed ID: 24407711
[TBL] [Abstract][Full Text] [Related]
5. CT-guided High-Dose-Rate Brachytherapy versus Transarterial Chemoembolization in Patients with Unresectable Hepatocellular Carcinoma.
Auer TA; Müller L; Schulze D; Anhamm M; Bettinger D; Steinle V; Haubold J; Zopfs D; Pinto Dos Santos D; Eisenblätter M; Gebauer B; Kloeckner R; Collettini F
Radiology; 2024 Feb; 310(2):e232044. PubMed ID: 38319166
[TBL] [Abstract][Full Text] [Related]
6. Comparison of intrahepatic progression patterns of hepatocellular carcinoma and colorectal liver metastases following CT-guided high dose-rate brachytherapy.
Xu H; Schmidt R; Hamm CA; Schobert IT; He Y; Böning G; Jonczyk M; Hamm B; Gebauer B; Savic LJ
Ther Adv Med Oncol; 2021; 13():17588359211042304. PubMed ID: 34539817
[TBL] [Abstract][Full Text] [Related]
7. Prospective evaluation of CT-guided HDR brachytherapy as a local ablative treatment for renal masses: a single-arm pilot trial.
Damm R; Streitparth T; Hass P; Seidensticker M; Heinze C; Powerski M; Wendler JJ; Liehr UB; Mohnike K; Pech M; Ricke J
Strahlenther Onkol; 2019 Nov; 195(11):982-990. PubMed ID: 31346674
[TBL] [Abstract][Full Text] [Related]
8. Computed tomography-guided interstitial HDR brachytherapy (CT-HDRBT) of the liver in patients with irresectable intrahepatic cholangiocarcinoma.
Schnapauff D; Denecke T; Grieser C; Collettini F; Seehofer D; Sinn M; Banzer J; Lopez-Hänninen E; Hamm B; Wust P; Gebauer B
Cardiovasc Intervent Radiol; 2012 Jun; 35(3):581-7. PubMed ID: 21833806
[TBL] [Abstract][Full Text] [Related]
9. Computed-tomography-guided high-dose-rate brachytherapy (CT-HDRBT) ablation of metastases adjacent to the liver hilum.
Collettini F; Singh A; Schnapauff D; Powerski MJ; Denecke T; Wust P; Hamm B; Gebauer B
Eur J Radiol; 2013 Oct; 82(10):e509-14. PubMed ID: 23791521
[TBL] [Abstract][Full Text] [Related]
10. Iodine-125 Brachytherapy Can Prolong Progression-Free Survival of Patients with Locoregional Recurrence and/or Residual Hepatocellular Carcinoma After Radiofrequency Ablation.
Chen L; Ying X; Zhang D; Lai L; Wu F; Tu J; Ji J
Cancer Biother Radiopharm; 2021 Dec; 36(10):820-826. PubMed ID: 32551979
[No Abstract] [Full Text] [Related]
11. Initial Experience with CT-Guided High-Dose-Rate Brachytherapy in the Multimodality Treatment of Neuroendocrine Tumor Liver Metastases.
Schippers AC; Collettini F; Steffen IG; Wieners G; Denecke T; Pavel M; Wust P; Gebauer B
J Vasc Interv Radiol; 2017 May; 28(5):672-682. PubMed ID: 27645463
[TBL] [Abstract][Full Text] [Related]
12. Activity-based cost analysis of hepatic tumor ablation using CT-guided high-dose rate brachytherapy or CT-guided radiofrequency ablation in hepatocellular carcinoma.
Schnapauff D; Collettini F; Steffen I; Wieners G; Hamm B; Gebauer B; Maurer MH
Radiat Oncol; 2016 Feb; 11():26. PubMed ID: 26911437
[TBL] [Abstract][Full Text] [Related]
13. Efficacy and safety of image-guided interstitial single fraction high-dose-rate brachytherapy in the management of metastatic malignant melanoma.
Bretschneider T; Mohnike K; Hass P; Seidensticker R; Göppner D; Dudeck O; Streitparth F; Ricke J
J Contemp Brachytherapy; 2015 Apr; 7(2):154-60. PubMed ID: 26034497
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous computed tomography-guided high-dose-rate brachytherapy ablation of breast cancer liver metastases: initial experience with 80 lesions.
Collettini F; Golenia M; Schnapauff D; Poellinger A; Denecke T; Wust P; Riess H; Hamm B; Gebauer B
J Vasc Interv Radiol; 2012 May; 23(5):618-26. PubMed ID: 22525020
[TBL] [Abstract][Full Text] [Related]
15. CT-guided brachytherapy as salvage therapy for intrahepatic recurrence of HCC after surgical resection.
Schnapauff D; Collettini F; Hartwig K; Wieners G; Chopra S; Hamm B; Gebauer B
Anticancer Res; 2015 Jan; 35(1):319-23. PubMed ID: 25550566
[TBL] [Abstract][Full Text] [Related]
16. Diffusion-weighted MRI (DWI) for assessment of response to high-dose-rate CT-guided brachytherapy (HDR-BT) of hepatocellular carcinoma.
Karim H; Thormann M; Omari J; Surov A; Schinner R; Seidensticker R; Ingenerf M; Ricke J; Schmid-Tannwald C
Acta Radiol; 2024 Jan; 65(1):14-22. PubMed ID: 36843430
[TBL] [Abstract][Full Text] [Related]
17. [Percutaneous CT-guided high-dose brachytherapy (CT-HDRBT) ablation of primary and metastatic lung tumors in nonsurgical candidates].
Collettini F; Schnapauff D; Poellinger A; Denecke T; Banzer J; Golenia MJ; Wust P; Gebauer B
Rofo; 2012 Apr; 184(4):316-23. PubMed ID: 22297915
[TBL] [Abstract][Full Text] [Related]
18. Computed tomography-guided high-dose-rate brachytherapy in hepatocellular carcinoma: safety, efficacy, and effect on survival.
Mohnike K; Wieners G; Schwartz F; Seidensticker M; Pech M; Ruehl R; Wust P; Lopez-Hänninen E; Gademann G; Peters N; Berg T; Malfertheiner P; Ricke J
Int J Radiat Oncol Biol Phys; 2010 Sep; 78(1):172-9. PubMed ID: 20056348
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and safety in radiofrequency ablation of pulmonary metastases from HCC: a five years study.
Lassandro G; Picchi SG; Bianco A; Di Costanzo G; Coppola A; Ierardi AM; Lassandro F
Med Oncol; 2020 Mar; 37(4):25. PubMed ID: 32166529
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of
Xiang Z; Bai M; Li G; Zou B; Zhong Z; Gao F; Wu C; Huang M; Zhang F
J Cancer Res Clin Oncol; 2019 Jul; 145(7):1907-1916. PubMed ID: 31161374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
